$MRVL Marvell Technology Group (MRVL) Overall Average: 80% Buy.

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Ares Capital got traders buzzing back when it offered a solid yield of around 9%. It stood out as the largest publicly traded business development company (BDC) globally, which made income-focused investors take notice. But here’s the kicker: BDCs like Ares can sidestep corporate taxes if they hand out most of their earnings as dividends, creating a prime hunting ground...

Keurig Dr Pepper Welcomes New Chief Financial Officer Keurig Dr Pepper (NASDAQ: KDP) recently announced an exciting leadership change with the appointment of Anthony DiSilvestro as its new Chief Financial Officer. This important transition marks a significant step as DiSilvestro steps into his role immediately, bringing over four decades of extensive experience across...

Elisa Unveils Elisa Industriq: A New Era in Software Solutions Elisa Oyj is excited to announce a significant milestone as it consolidates its international digital services under a unified brand known as Elisa Industriq. This initiative aims to streamline its software offerings and create a robust identity within the market. Following this change, Elisa will report the...

Driving Community Support Through Strategic Grants The American Water Charitable Foundation and Illinois American Water are making waves by putting their money where their mouth is, delivering a batch of state strategic impact grants to United Way organizations that promise to spark some serious change. It’s not every day you see such a duo diving into local communities...

Essity Faces Early Bond Repayment Demand Amid Dispute Essity has found itself in a challenging situation. Recently, a handful of bondholders have made a demand for the early repayment of bonds that are set to mature in the upcoming years of 2029, 2030, and 2031. This unexpected request has prompted Essity to reaffirm its position and contest the claims of these...